GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocept Inc (FRA:B00) » Definitions » E10

Biocept (FRA:B00) E10 : €-132,160.00 (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biocept E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biocept's adjusted earnings per share data for the three months ended in Jun. 2023 was €-3.231. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-132,160.00 for the trailing ten years ended in Jun. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-31), Biocept's current stock price is €6.80. Biocept's E10 for the quarter that ended in Jun. 2023 was €-132,160.00. Biocept's Shiller PE Ratio of today is .


Biocept E10 Historical Data

The historical data trend for Biocept's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocept E10 Chart

Biocept Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -25,515.00 -21,136.90

Biocept Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28,953.10 -27,979.10 -21,136.90 -21,708.20 -132,160.00

Competitive Comparison of Biocept's E10

For the Diagnostics & Research subindustry, Biocept's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocept's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocept's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biocept's Shiller PE Ratio falls into.



Biocept E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biocept's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-3.231/128.7287*128.7287
=-3.231

Current CPI (Jun. 2023) = 128.7287.

Biocept Quarterly Data

per share eps CPI Adj_EPS
201309 -12,810.921 98.790 -16,693.321
201312 -10,805.752 98.326 -14,146.938
201403 -22,606.402 99.695 -29,190.103
201406 -13,449.222 100.560 -17,216.681
201409 -18,263.393 100.428 -23,410.080
201412 -19,194.667 99.070 -24,941.072
201503 -5,304.943 99.621 -6,854.958
201506 -5,210.550 100.684 -6,661.912
201509 -5,764.182 100.392 -7,391.220
201512 -5,822.617 99.792 -7,510.972
201603 -5,916.123 100.470 -7,580.091
201606 -4,425.125 101.688 -5,601.841
201609 -4,529.559 101.861 -5,724.313
201612 -2,303.659 101.863 -2,911.243
201703 -1,767.169 102.862 -2,211.555
201706 -1,687.440 103.349 -2,101.827
201709 -1,485.030 104.136 -1,835.741
201712 -1,368.917 104.011 -1,694.232
201803 -810.189 105.290 -990.551
201806 -693.360 106.317 -839.522
201809 -622.182 106.507 -751.997
201812 -377.091 105.998 -457.957
201903 -161.955 107.251 -194.388
201906 -100.890 108.070 -120.177
201909 -67.283 108.329 -79.953
201912 -54.000 108.420 -64.115
202003 -28.779 108.902 -34.019
202006 -13.586 108.767 -16.079
202009 -9.424 109.815 -11.047
202012 3.452 109.897 4.044
202103 4.788 111.754 5.515
202106 -3.486 114.631 -3.915
202109 -1.020 115.734 -1.135
202112 -4.779 117.630 -5.230
202203 -3.541 121.301 -3.758
202206 -16.858 125.017 -17.359
202209 -18.180 125.227 -18.688
202212 -16.142 125.222 -16.594
202303 -11.488 127.348 -11.613
202306 -3.231 128.729 -3.231

Add all the adjusted EPS together and divide 10 will get our e10.


Biocept  (FRA:B00) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biocept E10 Related Terms

Thank you for viewing the detailed overview of Biocept's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocept (FRA:B00) Business Description

Traded in Other Exchanges
Address
9955 Mesa Rim Road, San Diego, CA, USA, 92121
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Biocept (FRA:B00) Headlines

No Headlines